These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


658 related items for PubMed ID: 34861847

  • 1. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.
    Lin H, Shi X, Li H, Hui J, Liu R, Chen Z, Lu Y, Tan W.
    BMC Cancer; 2021 Dec 03; 21(1):1293. PubMed ID: 34861847
    [Abstract] [Full Text] [Related]

  • 2. Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.
    El-Shal AS, Shalaby SM, Abouhashem SE, Elbary EHA, Azazy S, Rashad NM, Sarhan W.
    Mol Biol Rep; 2021 May 03; 48(5):4361-4371. PubMed ID: 34085193
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urinary Exosomal miR-17-5p Accelerates Bladder Cancer Invasion by Repressing its Target Gene ARID4B and Regulating the Immune Microenvironment.
    Yuan H, Wang T, Peng P, Xu Z, Feng F, Cui Y, Ma J, Wu J.
    Clin Genitourin Cancer; 2024 Apr 03; 22(2):569-579.e1. PubMed ID: 38383173
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.
    Itesako T, Seki N, Yoshino H, Chiyomaru T, Yamasaki T, Hidaka H, Yonezawa T, Nohata N, Kinoshita T, Nakagawa M, Enokida H.
    PLoS One; 2014 Apr 03; 9(2):e84311. PubMed ID: 24520312
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum Exosomal miR-17-5p as a Promising Biomarker Diagnostic Biomarker for Breast Cancer.
    Lv S, Wang Y, Xu W, Dong X.
    Clin Lab; 2020 Sep 01; 66(9):. PubMed ID: 32902214
    [Abstract] [Full Text] [Related]

  • 14. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L, Liu Y, Du L, Li J, Jiang X, Zheng G, Qu A, Wang H, Wang L, Zhang X, Liu H, Pan H, Yang Y, Wang C.
    Mol Med Rep; 2015 Jul 01; 12(1):615-22. PubMed ID: 25738263
    [Abstract] [Full Text] [Related]

  • 15. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
    Yoshimura A, Sawada K, Nakamura K, Kinose Y, Nakatsuka E, Kobayashi M, Miyamoto M, Ishida K, Matsumoto Y, Kodama M, Hashimoto K, Mabuchi S, Kimura T.
    BMC Cancer; 2018 Nov 05; 18(1):1065. PubMed ID: 30396333
    [Abstract] [Full Text] [Related]

  • 16. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M, Zhou Y, Xia T, Zhou X, Huang Z, Zhang H, Zhu W, Ding Q, Wang S.
    Breast Cancer Res Treat; 2018 Jul 05; 170(2):257-270. PubMed ID: 29557526
    [Abstract] [Full Text] [Related]

  • 17. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
    Min QH, Chen XM, Zou YQ, Zhang J, Li J, Wang Y, Li SQ, Gao QF, Sun F, Liu J, Xu YM, Lin J, Huang LF, Huang B, Wang XZ.
    J Clin Lab Anal; 2018 Feb 05; 32(2):. PubMed ID: 28383146
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis.
    Zou X, Xia T, Li M, Wang T, Liu P, Zhou X, Huang Z, Zhu W.
    Cancer Biomark; 2021 Feb 05; 30(1):41-53. PubMed ID: 32894240
    [Abstract] [Full Text] [Related]

  • 19. Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
    Güllü Amuran G, Tinay I, Filinte D, Ilgin C, Peker Eyüboğlu I, Akkiprik M.
    Int Urol Nephrol; 2020 Mar 05; 52(3):461-468. PubMed ID: 31679136
    [Abstract] [Full Text] [Related]

  • 20. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H, Zou X, Wu L, Zhang S, Wang T, Liu P, Zhu W, Zhu J.
    Cancer Med; 2020 Feb 05; 9(3):1230-1241. PubMed ID: 31856390
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.